Hosted on MSN1mon
MSD commences Phase III trial of DLBCL treatment
It is also under assessment in the Phase II/III waveLINE-003 dose confirmation and expansion trial for relapsed or refractory DLBCL, and in the waveLINE-007 study in conjunction with R-CHP for ...
Nature6y
Bortezomib enhances chemotherapy effects in ABC DLBCL
A study has shown that bortezomib can enhance the activity of doxorubicin-based chemotherapy for the treatment of activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL). This ...